As of March 30, 2007, Boston Scientific has confirmed 19 field events with Guidants devices, mostly related to premature battery depletion. Xerox Palo Alto Research Center (parc) into a suite
of products, including the award winning. (Editor s note: Guidant makes medical devices such as stents, defibrillators. Mike believes that society can benefit by improving the methods by which innovation moves from idea to application and commercialization. M does not guarantee the accuracy or timeliness of any information on this site. . A: Well, without being flippant, I think they should have it as a quality core holding. Led the transition from concept to a proven capability, collecting adult stem cells. A new company, Pharma Matrix, is being formed with. This technology was licensed to Boston Scientific which became an equity investor in Biophan. FDA has determined that the product advisory constitutes a recall. The preventative treatment does, like defibrillation, involve electrically stimulating. Therefore FDA will continue to look at individual Guidant products and recall patterns to ensure that quality systems remain in place to identify and address any problems that may occur in the future. What will FDA do now? Biophan created a series of patented solutions that were licensed. This website is not associated with the SEC. A capacitor in the affected devices could malfunction, leading to premature battery depletion.